Anne Marie Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anne Marie Singh has a total of 232 co-authors. Here are the top co-authors by number of shared publications:
Melanie Makhija
Division of Allergy and Immunology, Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Ill; Division of Allergy and Immunology, Department of Pediatrics, Northwestern Feinberg School of Medicine, Chicago, Ill; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill
5 shared publicationsCasper Bendixsen
3 shared publicationsJames E. Gern
3 shared publicationsMeagan Yong
Division of Allergy and Immunology, Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Ill
3 shared publications- Akhgar Ghassabian
Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States; Departments of Pediatrics, New York University Grossman School of Medicine, New York, NY, United States
2 shared publications Ashley L. Devonshire
From the Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, IL
2 shared publications
Latest Publications
- Open Access
- 23 December 2025
- Published by Elsevier in Environmental Research
- Vol. 292, 123529
Pre- and postnatal exposure to PM2.5 and NO2 and blood pressure in children: Results from the ECHO Cohort
- 23 December 2025
- Published by Elsevier in Environmental Research
- Vol. 292, 123529
Open AccessPre- and postnatal exposure to PM2.5 and NO2 and blood pressure in children: Results from the ECHO Cohort
- 2 December 2025
- Published by Elsevier in Environmental Pollution
- Vol. 392, 127452
Racial and ethnic disparities in environmental chemical exposures and hypertensive disorders of pregnancy: The ECHO-wide cohort study
- 2 December 2025
- Published by Elsevier in Environmental Pollution
- Vol. 392, 127452
Racial and ethnic disparities in environmental chemical exposures and hypertensive disorders of pregnancy: The ECHO-wide cohort study
- Open Access
- 2 June 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (6) , e2515094
Phenotypes of Atopic Dermatitis and Development of Allergic Diseases
Importance: Atopic dermatitis (AD) is the most common inflammatory disease in childhood, and children with AD are more likely to develop other allergic diseases, including food allergy, allergic rhinitis, and asthma.Objective: To determine the phenotypes of AD expression across 12 US birth cohorts and identify factors associated with phenotype and development of allergic diseases.Design, Setting, and Participants: This cohort study compiled longitudinal data from 12 observational US birth cohorts across decades (children born from April 1980 to June 2019) in the Environmental Influences on Child Health Outcomes (ECHO) Children’s Respiratory and Environmental Workgroup with follow-up to September 2022. Participants were enrolled prenatally; children with 3 or more AD assessments across the first 84 months of life were included in analyses. Data were analyzed from December 2020 to April 2024.Exposures: Exposures included decade of birth, cohort type (population-based or high-risk), family history of asthma (mother, father, or sibling), birth order, gestational age at birth, delivery mode, breastfeeding, pet exposure, antibiotic use, environmental tobacco smoke exposure, allergic sensitization, peripheral blood eosinophil count, and total IgE.Main Outcomes and Measures: Primary outcomes were AD phenotype, food allergy, allergic rhinitis, asthma, and wheeze. Longitudinal latent class analysis was used to identify underlying longitudinal patterns of AD expression, and associations of AD phenotype with allergic outcomes were examined using logistic regression, multinomial logistic regression, and linear regression.Results: In 5314 children from 9 cohorts (1896 born in the 2000s [35.7%]; 2585 female [48.6%]; 1083 Black or African American [20.4%]; 3344 White [62.9%]; 350 other reported race [6.6%; including 8 American Indian or Alaska Native (0.2%); 58 Asian (1.1%); 4 Native Hawaiian or Pacific Islander (0.1%) and 280 multiracial or with any race not otherwise specified (5.3%)]), 3382 (63.6%) were from a population-based cohort, while 1932 (36.4%) were from a high-risk cohort. AD prevalence ranged from 24.1% (540 children) to 28.4% (1156 children) at each time point, and 5 phenotypes of AD were identified: transient early AD, early AD with potential reoccurrence, late-onset AD, persistent AD, and minimal or no AD. Compared with White children, Black children were at higher risk for AD (transient early AD: aOR, 3.26; 95% CI, 2.06-5.18; early AD with potential reoccurrence: aOR, 3.72; 95% CI, 2.35-5.90; persistent AD: aOR, 2.01; 95% CI, 1.54-2.63), as were children with other reported race (transient early AD: aOR, 2.31; 95% CI, 1.13-4.70; early AD with potential reoccurrence: aOR, 3.27; 95% CI, 1.73-6.18). Female children were significantly less likely to have early AD with potential reoccurrence (aOR, 0.45; 95% CI, 0.27-0.74) and persistent AD (aOR, 0.60; 95% CI, 0.49-0.74) than male children. Compared with miniml or no AD, phenotypes with early AD expression were associated with food allergy (transient early AD: adjusted odds ratio [aOR], 2.15; 95% CI, 1.48-3.08; early AD with potential reoccurrence: aOR, 2.43; 95% CI, 1.66-3.50; persistent AD: aOR, 2.26; 95% CI, 1.84-2.78), later AD expression was associated with allergic rhinitis (late-onset AD: aOR, 1.84; 95% CI, 1.38-2.43; persistent AD: aOR, 2.02; 95% CI, 1.64-2.48), and any AD disease was associated with asthma.Conclusions and Relevance: In this birth cohort study of 5314 children, timing of AD expression was associated with increased risk for atopic march pathways. Identifying risk factors for AD phenotypes may inform targeted therapeutic prevention strategies.
- 2 June 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (6) , e2515094
Open AccessPhenotypes of Atopic Dermatitis and Development of Allergic Diseases
Importance: Atopic dermatitis (AD) is the most common inflammatory disease in childhood, and children with AD are more likely to develop other allergic diseases, including food allergy, allergic rhinitis, and asthma.Objective: To determine the phenotypes of AD expression across 12 US birth cohorts and identify factors associated with phenotype and development of allergic diseases.Design, Setting, and Participants: This cohort study compiled longitudinal data from 12 observational US birth cohorts across decades (children born from April 1980 to June 2019) in the Environmental Influences on Child Health Outcomes (ECHO) Children’s Respiratory and Environmental Workgroup with follow-up to September 2022. Participants were enrolled prenatally; children with 3 or more AD assessments across the first 84 months of life were included in analyses. Data were analyzed from December 2020 to April 2024.Exposures: Exposures included decade of birth, cohort type (population-based or high-risk), family history of asthma (mother, father, or sibling), birth order, gestational age at birth, delivery mode, breastfeeding, pet exposure, antibiotic use, environmental tobacco smoke exposure, allergic sensitization, peripheral blood eosinophil count, and total IgE.Main Outcomes and Measures: Primary outcomes were AD phenotype, food allergy, allergic rhinitis, asthma, and wheeze. Longitudinal latent class analysis was used to identify underlying longitudinal patterns of AD expression, and associations of AD phenotype with allergic outcomes were examined using logistic regression, multinomial logistic regression, and linear regression.Results: In 5314 children from 9 cohorts (1896 born in the 2000s [35.7%]; 2585 female [48.6%]; 1083 Black or African American [20.4%]; 3344 White [62.9%]; 350 other reported race [6.6%; including 8 American Indian or Alaska Native (0.2%); 58 Asian (1.1%); 4 Native Hawaiian or Pacific Islander (0.1%) and 280 multiracial or with any race not otherwise specified (5.3%)]), 3382 (63.6%) were from a population-based cohort, while 1932 (36.4%) were from a high-risk cohort. AD prevalence ranged from 24.1% (540 children) to 28.4% (1156 children) at each time point, and 5 phenotypes of AD were identified: transient early AD, early AD with potential reoccurrence, late-onset AD, persistent AD, and minimal or no AD. Compared with White children, Black children were at higher risk for AD (transient early AD: aOR, 3.26; 95% CI, 2.06-5.18; early AD with potential reoccurrence: aOR, 3.72; 95% CI, 2.35-5.90; persistent AD: aOR, 2.01; 95% CI, 1.54-2.63), as were children with other reported race (transient early AD: aOR, 2.31; 95% CI, 1.13-4.70; early AD with potential reoccurrence: aOR, 3.27; 95% CI, 1.73-6.18). Female children were significantly less likely to have early AD with potential reoccurrence (aOR, 0.45; 95% CI, 0.27-0.74) and persistent AD (aOR, 0.60; 95% CI, 0.49-0.74) than male children. Compared with miniml or no AD, phenotypes with early AD expression were associated with food allergy (transient early AD: adjusted odds ratio [aOR], 2.15; 95% CI, 1.48-3.08; early AD with potential reoccurrence: aOR, 2.43; 95% CI, 1.66-3.50; persistent AD: aOR, 2.26; 95% CI, 1.84-2.78), later AD expression was associated with allergic rhinitis (late-onset AD: aOR, 1.84; 95% CI, 1.38-2.43; persistent AD: aOR, 2.02; 95% CI, 1.64-2.48), and any AD disease was associated with asthma.Conclusions and Relevance: In this birth cohort study of 5314 children, timing of AD expression was associated with increased risk for atopic march pathways. Identifying risk factors for AD phenotypes may inform targeted therapeutic prevention strategies.
- 8 August 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (11) , 3089-3095.e2
Prevalence and Characteristics of Accidental Ingestions Among Pediatric Food Allergy Patients
- 8 August 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (11) , 3089-3095.e2
Prevalence and Characteristics of Accidental Ingestions Among Pediatric Food Allergy Patients
- Open Access
- 1 May 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (3) , 100270
Research protocol and recruitment redesign of a study of pregnant women and their infants during the COVID-19 pandemic: Childhood Allergy and the NeOnatal Environment (CANOE)
- 1 May 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (3) , 100270
Open AccessResearch protocol and recruitment redesign of a study of pregnant women and their infants during the COVID-19 pandemic: Childhood Allergy and the NeOnatal Environment (CANOE)
- Open Access
- 15 April 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (3) , 100259
Combined metagenomic- and culture-based approaches to investigate bacterial strain–level associations with medication-controlled mild-moderate atopic dermatitis
- 15 April 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (3) , 100259
Open AccessCombined metagenomic- and culture-based approaches to investigate bacterial strain–level associations with medication-controlled mild-moderate atopic dermatitis
- 2 March 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 153 (6) , 1604-1610.e2
Atopic dermatitis phenotype affects expression of atopic diseases despite similar mononuclear cell cytokine response
- 2 March 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 153 (6) , 1604-1610.e2
Atopic dermatitis phenotype affects expression of atopic diseases despite similar mononuclear cell cytokine response
- 5 October 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (10) , 3283-3284
Reply to “Recurrences in food protein–induced enterocolitis syndrome: Let’s get the label right”
- 5 October 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (10) , 3283-3284
Reply to “Recurrences in food protein–induced enterocolitis syndrome: Let’s get the label right”
- Open Access
Combined metagenomic- and culture-based approaches to investigate bacterial strain-level associations with medication-controlled mild-moderate atopic dermatitis
Background: The skin microbiome is disrupted in atopic dermatitis (AD). Existing research focuses on moderate-severe, unmedicated disease. Objective: Investigate metagenomic- and culture-based bacterial strain-level differences in mild, medicated AD, and the effects these have on human keratinocytes (HK). Methods: Skin swabs from anterior forearms were collected from 20 pediatric participants; 11 participants with AD sampled at lesional and nonlesional sites and 9 age- and sex-matched controls). Participants had primarily mild-moderate AD and maintained medication use. Samples were processed for microbial metagenomic sequencing and bacterial isolation. Isolates identified as S. aureus were tested for enterotoxin production. HK cultures were treated with cell free conditioned media from representative Staphylococcus species to measure barrier effects. Results: Metagenomic sequencing identified significant differences in microbiome composition between AD and control groups. Differences were seen at the species- and strain-levels for Staphylococci , with S. aureus only found in AD participants and differences in S. epidermidis strains between control and AD swabs. These strains showed differences in toxin gene presence, which was confirmed in vitro for S. aureus enterotoxins. The strain from the most severe AD participant produced enterotoxin B levels >100-fold higher than the other strains (pStaphylococcus strains may explain varying effects on HK, with S. aureus and non-aureus strains negatively impacting viability and barrier function. These differences are likely important in AD pathogenesis. KEY MESSAGES: Staphylococcal strain effects, more so than species effects, impact keratinocyte barrier function and metabolism, suggesting that strain level differences, and not species-level, may be critical in AD pathogenesis. The microbiome from mild, medicated atopic dermatitis patients harbor Staphylococcus strains with detrimental effects on skin barrier, and may not only be mediated by S. aureus . CAPSULE SUMMARY: Patients with mild atopic dermatitis controlled by medication may still harbor strains of Staphylococcus spp. that carry toxins that negatively impact skin barrier function.
Open AccessCombined metagenomic- and culture-based approaches to investigate bacterial strain-level associations with medication-controlled mild-moderate atopic dermatitis
Background: The skin microbiome is disrupted in atopic dermatitis (AD). Existing research focuses on moderate-severe, unmedicated disease. Objective: Investigate metagenomic- and culture-based bacterial strain-level differences in mild, medicated AD, and the effects these have on human keratinocytes (HK). Methods: Skin swabs from anterior forearms were collected from 20 pediatric participants; 11 participants with AD sampled at lesional and nonlesional sites and 9 age- and sex-matched controls). Participants had primarily mild-moderate AD and maintained medication use. Samples were processed for microbial metagenomic sequencing and bacterial isolation. Isolates identified as S. aureus were tested for enterotoxin production. HK cultures were treated with cell free conditioned media from representative Staphylococcus species to measure barrier effects. Results: Metagenomic sequencing identified significant differences in microbiome composition between AD and control groups. Differences were seen at the species- and strain-levels for Staphylococci , with S. aureus only found in AD participants and differences in S. epidermidis strains between control and AD swabs. These strains showed differences in toxin gene presence, which was confirmed in vitro for S. aureus enterotoxins. The strain from the most severe AD participant produced enterotoxin B levels >100-fold higher than the other strains (pStaphylococcus strains may explain varying effects on HK, with S. aureus and non-aureus strains negatively impacting viability and barrier function. These differences are likely important in AD pathogenesis. KEY MESSAGES: Staphylococcal strain effects, more so than species effects, impact keratinocyte barrier function and metabolism, suggesting that strain level differences, and not species-level, may be critical in AD pathogenesis. The microbiome from mild, medicated atopic dermatitis patients harbor Staphylococcus strains with detrimental effects on skin barrier, and may not only be mediated by S. aureus . CAPSULE SUMMARY: Patients with mild atopic dermatitis controlled by medication may still harbor strains of Staphylococcus spp. that carry toxins that negatively impact skin barrier function.